Syrian opposition hopeful war in Syria will end due to Russia’s roleWorld January 24, 16:14
Aleppo's historical sights after Syrian civil warWorld January 24, 15:36
Russia, Iran, Turkey agree to set up ceasefire monitoring mechanism in SyriaWorld January 24, 15:30
US withdrawal from TPP will not change Russia’s agenda in Asian region — deputy ministerBusiness & Economy January 24, 15:12
Gazprom chairman says gas will follow oil in global energy balance by 2040Business & Economy January 24, 14:41
IAC says Boeing crashed outside Bishkek was in good technical conditionWorld January 24, 14:24
Syria ceasefire monitoring mechanism may be included in separate document — sourceWorld January 24, 14:11
Italian top diplomat urges EU and US to solve sanctions issue togetherWorld January 24, 14:06
World athletics body to give timeframe for admitting Russian athletes to competitionsSport January 24, 13:36
MOSCOW, June 19. /ITAR-TASS/. Russian pharmaceutical producer R-Pharm will invest €30 million in constructing a biotechnological plant in Turkey, CEO Vasily Ignatyev said late on Wednesday.
In 2013, R-Pharm established a joint venture with a Turkish partner aimed at selling R-Pharm’s medicines in Turkey, the Middle East and the northern Africa.
“We hope to get all necessary documents for clearance until the end of the year and to start the earthworks. We plan to finish the construction and to set up equipment until the end of 2016. The commercial launch will be made, as we expect, in late 2017,” Ignatyev said.
R-Pharm will invest €100 million in its Turkish business until 2018, he said.
Ignatyev separately said that the company will close the deal to purchase a plant from a large pharmaceutical company in Germany until the end of 2014.